No profile data available.
Pacific Biosciences of California, Inc. (PACB) is a healthcare company in the biological analysis equipment industry, based in Menlo Park, United States, with about 485 full-time employees.
It reported revenue of $160.01 million for fiscal year 2025, up 3.9% from fiscal year 2024, and net income of -$546.38 million. United States of America was its largest region in fiscal year 2025, with 44% of revenue. Its market capitalization was $724.24 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems.
Pacific Biosciences of California reported $160.01 million in revenue for fiscal year 2025, up 3.9% from $154.01 million in fiscal year 2024.
United States of America: 44% of revenue by region in fiscal year 2025, followed by Europe, Middle East and Africa (28%).
$724.24 million as of October 9, 2026.
Listed companies of a similar size in the same industry (biological analysis equipment) include Neogen Corporation (NEOG), 10x Genomics, Inc. (TXG), BioLife Solutions, Inc. (BLFS), Cytek Biosciences, Inc. (CTKB).